A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects
Clinical trial NCT02019485 · COMPLETED
Trial details
- NCT number
- NCT02019485
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.